What is KPV? Three amino acids, and that's the whole molecule: lysine, proline and valine, written K, P and V. The name is literally its ingredient list. It turns up in multi-peptide research blends, so plenty of people figure it's a new lab invention from the peptide boom. It isn't.
What is KPV? The last three links of a natural hormone
KPV is the tail end of alpha-MSH, a natural hormone 13 amino acids long. Researchers snipped off those last three links to see what the tail does without the rest. Picture tearing the last line off a letter and reading it on its own. Sometimes it still makes sense. Sometimes it doesn't.
The proof: what the tail kept, and what it lost
Here's what's actually going on.
The parent hormone is named after pigment cells. MSH stands for melanocyte-stimulating hormone, and melanocytes are the cells that make pigment. Alpha-MSH is cut from a bigger precursor protein called POMC. KPV sits at positions 11 to 13, the very end.
The tail kept one job and dropped another. A 2008 review from the University of Münster lays it out. Alpha-MSH drew interest in lab models of inflammation, but its pigment action got in the way. The review describes KPV as keeping the inflammation-related activity seen in those studies while lacking the pigment action (Brzoska et al., Endocr Rev 2008).
Being tiny opens a different door. Cells lining the gut carry a transporter called PepT1 that moves peptides just two or three amino acids long. Think of a mail slot that only takes postcards. In 2008 an Emory University team showed KPV gets into human gut cells grown in a dish through that slot. They also tested it in two mouse models of colitis, gut inflammation set off on purpose in the lab (Dalmasso et al., Gastroenterology 2008). A 13-link hormone doesn't fit that slot.
Then it became a packaging problem. Many of the KPV papers since are about delivery. In 2010 the same Emory group loaded it into particles about 400 nanometers wide, wrapped them in a gel built to break open in the colon, and tested that in mice (Laroui et al., Gastroenterology 2010). In 2021 a team at Wenzhou Medical University in China tried a gel in rats (Sun et al., ACS Biomater Sci Eng 2021).
So why should you care? Count the people. ClinicalTrials.gov lists no registered trials of KPV. The FDA says it hasn't found any human exposure data on KPV by any route (FDA). So far it's a cell-and-rodent story.
"Can a lab even confirm something that small?" It can, with a quirk. PubChem lists KPV at 342 daltons, about a fifth the weight of alpha-MSH at about 1,665. Reshuffle the same three into Val-Pro-Lys and PubChem lists the exact same weight, 342.43. So on a KPV certificate, the LC-MS identity result should land near 342. That match fits the right three building blocks. On its own, a mass can't tell you their order.
The big learning lesson
Keep reading: Three-peptide vs four-peptide blends: what's in each · The FDA "peptide ban" of 2026: what actually happened · How to read a peptide certificate of analysis
Frequently asked questions
What is KPV peptide made of?
Three amino acids: lysine (K), proline (P) and valine (V). They're positions 11 to 13 of alpha-MSH, a natural hormone 13 amino acids long.
Is KPV the same as alpha-MSH?
No. KPV is the last three amino acids of alpha-MSH. PubChem lists KPV at about 342 daltons and alpha-MSH at about 1,665, and a 2008 review describes KPV as lacking the parent hormone's pigment action.
Is KPV FDA approved?
No. On July 23, 2026 an FDA advisory committee voted 8 to 6, with one abstention, to recommend KPV for the pharmacy compounding list. That's a non-binding recommendation, not a drug approval, and the FDA says it hasn't identified any human exposure data on KPV.